Rohto Pharmaceutical Co.,Ltd. Revenue

Rohto Pharmaceutical Co.,Ltd. had revenue of 70.73B JPY in the quarter ending September 30, 2024, with 6.04% growth. This brings the company's revenue in the last twelve months to 282.05B, up 10.08% year-over-year. In the fiscal year ending March 31, 2024, Rohto Pharmaceutical Co.,Ltd. had annual revenue of 270.84B with 13.48% growth.

Revenue (ttm)

282.05B

Revenue Growth

+10.08%

P/S Ratio

2.19

Revenue / Employee

38.86M

Employees

7,259

Market Cap

618.37B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	270.84B	32.18B	13.48%
Mar 31, 2023	238.66B	39.02B	19.54%
Mar 31, 2022	199.65B	18.36B	10.13%
Mar 31, 2021	181.29B	-7.04B	-3.74%
Mar 31, 2020	188.33B	4.75B	2.58%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Japan Tobacco	3,077.34B
Seven & i Holdings	10.34T
Ajinomoto Co.	1,495.48B
Kao Corporation	1,596.71B
Pan Pacific International Holdings	2,136.34B
Asahi Group Holdings	2,914.04B
Unicharm	976.41B
Kirin Holdings Company	2,286.24B

Revenue Rankings